Back
Lonza Group Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
75
LZAGY
Lonza Group
Last Price:
65.83
Seasonality Move:
3.34%
Sell
50
CRSP
CRISPR Therapeutics AG
Last Price:
57.88
Seasonality Move:
-18.8%
Buy
75
Lonza Group (LZAGY)
is a Buy
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGY] share price is $63.67. The Score for LZAGY is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- LZAGY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $57.57. The Score for CRSP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LZAGY Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $63.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LZAGY is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $57.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
LZAGY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.29 | Buy |
Relative Strength Index (14 RSI): | 79.79 | Buy |
Chaikin Money Flow: | 22425 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.09 - 58.63) | Buy |
Bollinger Bands (100): | (53.97 - 58.73) | Buy |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 51.47 | Buy |
Chaikin Money Flow: | 335755 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.94 - 58.54) | Buy |
Bollinger Bands (100): | (53.02 - 68.4) | Sell |
LZAGY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.63 | Buy |
20-day SMA: | 56.96 | Buy |
50-day SMA: | 55.89 | Buy |
200-day SMA: | 49.53 | Buy |
8-day EMA: | 59.15 | Buy |
20-day EMA: | 57.54 | Buy |
50-day EMA: | 56.39 | Buy |
200-day EMA: | 53.52 | Buy |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.54 | Buy |
20-day SMA: | 55.98 | Buy |
50-day SMA: | 57.13 | Buy |
200-day SMA: | 61.37 | Sell |
8-day EMA: | 56.82 | Buy |
20-day EMA: | 56.84 | Buy |
50-day EMA: | 57.61 | Sell |
200-day EMA: | 59.88 | Sell |
Lonza Group Earnings Growth & LZAGY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, a decrease next quarter of $0.01 per share, a decrease this year of $2.53 per share, and an increase next year of $1.20 per share.
Lonza Group Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |